Insight Article
The benefits of finance and accounting outsourcing for life sciences
Learn how growing life sciences companies leverage finance and accounting outsourcing to enhance the finance function and focus on core competencies.
Ideas & Insights
Insight Article
IRS legal advice requires capitalization of ANDA costs
A review of IRS rulings on the proper treatment of similar expenses that were incurred by a pharmaceutical company.
Insight Article
Mass. court holds biotech firm engaged in substantial manufacturing
California biotech firm sees larger corporate tax bill after Massachusetts high court determination that it was engaged in manufacturing.
Insight Article
Base erosion and anti-abuse tax: Gross receipts calculation
Life sciences companies making payments to related foreign parties should be aware of how to determine the gross receipts calculation.
Insight Article
What life sciences boards need to understand about corruption risk
Learn what the board and others who have executive oversight of life sciences companies need to understand about minimizing corruption risk.
Insight Article
Contract compliance audits uncover life sciences company lost profits
RSM’s life sciences industry insider shares key insights and benefits of conducting a third-party contract compliance audit.
Insight Article
Improvements to employee share-based payment accounting
Learn about improvements to the share-based compensation standard and its impact on the life sciences industry.
Insight Article
Life sciences 2017 tax year in review—And a look ahead
Tax highlights for life sciences companies as you prepare for year-end filing and a look ahead to prepare for 2018.
Insight Article
Third parties, 3 risks and your life sciences business
Third parties provide a vital business partnership for growing life sciences companies, but there are risks to consider.
Insight Article
Finance & Accounting for Bioscience Companies conference: Key insights
Conference speakers shared insights on how to effectively scale bioscience businesses as well as best practices on accounting and reporting.
Insight Article
Life sciences companies: Is your third party FCPA-compliant?
Learn considerations for life sciences companies when it comes to FCPA compliance and third party risk management.
Insight Article
Life sciences companies: Revenue recognition is changing
Learn about key areas life sciences companies should address and steps they should take to implement the new revenue recognition guidance.
Insight Article
Understanding R&D credit benefits for the life sciences industry
Resources to help you gain an understanding of the eligibility criteria and re-examine your eligibility for the R&D credit.